Lv1
18 积分 2025-09-04 加入
Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trial
7小时前
已完结
siRNAs targeting ANGPTL3 for mixed dyslipidemia
4天前
已完结
Apolipoprotein B-containing lipoproteins in atherogenesis
9个月前
已完结
皖公网安备34019202002308
